Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
2.98
Oct 20 • 2:31 PM ET Dollar change+0.12 Percentage change(4.20%)
Index
-
Market Cap
46.30M
Enterprise Value
45.57M
Income
-21.41M
Sales
1.40M
Book/sh
6.66
Cash/sh
0.62
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9
IPO
Jan 25, 2018
P/E
-
Forward P/E
1.23
PEG
-
P/S
33.07
P/B
0.45
P/C
4.80
P/FCF
-
EV/EBITDA
-
EV/Sales
32.55
Quick Ratio
2.34
Current Ratio
2.34
Debt/Eq
0.09
LT Debt/Eq
0.06
Option/Short
No / Yes
EPS (ttm)
-3.44
EPS next Y
2.42
EPS next Q
2.31
EPS this Y
174.47%
EPS next Y
-65.43%
EPS next 5Y
-
EPS past 3/5Y
47.93% 34.01%
Sales past 3/5Y
- -16.47%
EPS Y/Y TTM
89.91%
Sales Y/Y TTM
3052.03%
EPS Q/Q
136.97%
Sales Q/Q
-
Insider Own
17.53%
Insider Trans
0.29%
Inst Own
17.00%
Inst Trans
-1.13%
ROA
7.88%
ROE
9.55%
ROIC
6.18%
Gross Margin
-
Oper. Margin
-1095.70%
Profit Margin
-1528.45%
SMA20
-16.04%
SMA50
-12.16%
SMA200
-11.83%
Trades
Shs Outstand
15.30M
Shs Float
12.82M
52W High
9.13 -67.36%
52W Low
2.34 27.35%
Volatility
7.96% 6.75%
ATR (14)
0.25
RSI (14)
38.82
Beta
2.74
Rel Volume
0.70
Avg Volume
458.77K
Volume
254,419
Perf Week
-11.31%
Perf Month
-22.60%
Perf Quarter
7.97%
Perf Half Y
-23.79%
Perf YTD
-16.29%
Perf Year
-60.74%
Perf 3Y
-97.13%
Perf 5Y
-99.36%
Perf 10Y
-
Prev Close
2.86
Price
2.98
Change %
4.20%
Date Action Analyst Rating Change Price Target Change
Dec-24-25Initiated Chardan Capital Markets Buy
Dec-16-25Initiated Cantor Fitzgerald Overweight $4
Nov-18-24Downgrade H.C. Wainwright Buy → Neutral $12 → $2
Mar-01-21Initiated Northland Capital Outperform $10
Feb-03-20Downgrade Oppenheimer Outperform → Perform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jung HyunsuSee RemarksJun 01 '26Buy3.707,00025,9201,384,676Jun 02 06:18 PM
Jung HyunsuSee RemarksJun 02 '26Buy3.661,0003,6601,385,676Jun 02 06:18 PM
Knox David R.Chief Financial OfficerDec 31 '25Buy3.5927,950100,340327,950Jan 05 08:00 AM
Strahlman Ellen RDirectorDec 29 '25Buy3.6012,11243,60391,161Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 29 '25Buy3.6111,85642,80034,869Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 26 '25Buy3.863,60113,91179,049Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 26 '25Buy3.863,31112,77723,013Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 18 '25Buy3.1419,70261,83595,150Dec 22 08:15 AM
Strahlman Ellen RDirectorDec 18 '25Buy3.1418,74258,82975,448Dec 22 08:15 AM
Walters Happy DavidDirectorDec 17 '25Buy3.0261,930187,152111,930Dec 19 07:21 PM
GELTZEILER MICHAEL SDirectorDec 17 '25Buy3.0130,00090,21088,015Dec 19 11:00 AM
Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid's native token HYPE. The firm provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. It operates through the following segments: Ophthalmic Technology and Digital Assets. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
CEOMr. Hyunsu Jung
Chief Financial Officer and TreasurerMr. David Knox C.F.A.
General Counsel & SecretaryMr. Robert Rubenstein
Investor ContactJason Assad
Investor ContactAlexander Lobo